Credit: ivanko80/Adobe Stock

The battle over access to a key drug used for medication abortions continues to heat up, both in a Texas courtroom and in the U.S. Senate.

Today, U.S. District Judge Matthew Kacsmaryk will hear arguments today in a case involving the U.S. Food and Drug Administration’s decades-old approval of the drug mifepristone, one of two medications used to terminate an early pregnancy. The plaintiffs asked Kacsmaryk to order the FDA to withdraw its approval of the drug, arguing that the agency mistakenly approved the drug under a regulation that allows accelerated approval of medications for “serious or life-threatening illnesses.”

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.